H19 and breast cancer: Furthermore, H19 was significantly increased in chemoresistant breast cancer tissues and Doxorubicin-reaiatant MCF-7/Dox cell lines compared with the chemosensitive breast cancer tissues Doxorubicin-sensitive MCF-7 cell lines.